GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lifecore Biomedical Inc (NAS:LFCR) » Definitions » Cyclically Adjusted Book per Share

LFCR (Lifecore Biomedical) Cyclically Adjusted Book per Share : $7.38 (As of Feb. 2025)


View and export this data going back to 1996. Start your Free Trial

What is Lifecore Biomedical Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Lifecore Biomedical's adjusted book value per share for the three months ended in Feb. 2025 was $0.060. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $7.38 for the trailing ten years ended in Feb. 2025.

During the past 12 months, Lifecore Biomedical's average Cyclically Adjusted Book Growth Rate was -9.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -1.80% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 1.50% per year. During the past 10 years, the average Cyclically Adjusted Book Growth Rate was 5.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Lifecore Biomedical was 9.80% per year. The lowest was -1.80% per year. And the median was 7.20% per year.

As of today (2025-06-25), Lifecore Biomedical's current stock price is $8.33. Lifecore Biomedical's Cyclically Adjusted Book per Share for the quarter that ended in Feb. 2025 was $7.38. Lifecore Biomedical's Cyclically Adjusted PB Ratio of today is 1.13.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Lifecore Biomedical was 2.52. The lowest was 0.19. And the median was 1.33.


Lifecore Biomedical Cyclically Adjusted Book per Share Historical Data

The historical data trend for Lifecore Biomedical's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifecore Biomedical Cyclically Adjusted Book per Share Chart

Lifecore Biomedical Annual Data
Trend May15 May16 May17 May18 May19 May20 May21 May22 May23 May24
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.99 8.49 9.02 8.70 8.03

Lifecore Biomedical Quarterly Data
May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.18 8.03 7.80 7.56 7.38

Competitive Comparison of Lifecore Biomedical's Cyclically Adjusted Book per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Lifecore Biomedical's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lifecore Biomedical's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lifecore Biomedical's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Lifecore Biomedical's Cyclically Adjusted PB Ratio falls into.


;
;

Lifecore Biomedical Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Lifecore Biomedical's adjusted Book Value per Share data for the three months ended in Feb. 2025 was:

Adj_Book= Book Value per Share /CPI of Feb. 2025 (Change)*Current CPI (Feb. 2025)
=0.06/134.6241*134.6241
=0.060

Current CPI (Feb. 2025) = 134.6241.

Lifecore Biomedical Quarterly Data

Book Value per Share CPI Adj_Book
201505 8.093 100.333 10.859
201508 8.229 100.548 11.018
201511 8.329 100.135 11.198
201602 7.575 100.040 10.194
201605 7.762 101.355 10.310
201608 7.903 101.617 10.470
201611 7.998 101.829 10.574
201702 8.153 102.779 10.679
201705 8.241 103.256 10.745
201708 8.346 103.587 10.847
201711 8.396 104.072 10.861
201802 9.023 105.052 11.563
201805 9.117 106.148 11.563
201808 9.131 106.383 11.555
201811 9.126 106.338 11.554
201902 9.311 106.649 11.753
201905 9.282 108.048 11.565
201908 9.090 108.245 11.305
201911 8.884 108.519 11.021
202002 8.487 109.139 10.469
202005 7.906 108.175 9.839
202008 7.563 109.662 9.285
202011 7.125 109.793 8.736
202102 6.978 110.968 8.466
202105 6.913 113.576 8.194
202108 6.580 115.421 7.675
202111 5.298 117.269 6.082
202202 4.887 119.703 5.496
202205 2.976 123.323 3.249
202208 3.274 124.958 3.527
202211 2.448 125.607 2.624
202302 1.128 126.928 1.196
202305 -0.143 128.314 -0.150
202308 -0.445 129.538 -0.462
202311 0.047 129.548 0.049
202402 0.579 130.930 0.595
202405 0.370 132.509 0.376
202408 -0.127 132.816 -0.129
202411 0.418 133.110 0.423
202502 0.060 134.624 0.060

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


Lifecore Biomedical  (NAS:LFCR) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Lifecore Biomedical's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=8.33/7.38
=1.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Lifecore Biomedical was 2.52. The lowest was 0.19. And the median was 1.33.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Lifecore Biomedical Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of Lifecore Biomedical's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Lifecore Biomedical Business Description

Traded in Other Exchanges
Address
3515 Lyman Boulevard, Chaska, MN, USA, 55318
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.
Executives
Wynnefield Partners Small Cap Value Lp I 10 percent owner 450 SEVENTH AVENUE, SUITE 509, NEW YORK NY 10123
Christopher S Kiper director 12121 WILSHIRE BLVD, SUITE 1240, LOS ANGELES CA 90025
Raymond T. White director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners, Llc director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners Holdings, Llc director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners, L.p. Ii director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners, L.p. I director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Legion Partners Asset Management, Llc director 12121 WILSHIRE BLVD., SUITE 1240, LOS ANGELES CA 90025
Nathaniel Calloway director C/O ANEBULO PHARMACEUTICALS, INC., 1415 RANCH ROAD 620 SOUTH, SUITE 201, LAKEWAY TX 78734
Raymond H Diradoorian director C/O LANDEC CORPORATION, 2811 AIRPARK DRIVE, SANTA MARIA CA 93455
Joshua Schechter director C/O THE PANTRY, INC., 305 GREGSON DRIVE, CARY NC 27511
Patrick D Walsh director 14282 FRANKLIN AVE., TUSTIN CA 92780
John D Morberg officer: Chief Financial Officer C/O LANDEC CORPORATION, 2811 AIRPARK DRIVE, SANTA MARIA CA 93455
Albert D. Bolles director CONAGRA FOODS, INC., ONE CONAGRA DRIVE, MS 1-330, OMAHA NE 68102
James G Hall officer: Executive Vice President 3515 LYMAN BLVD., CHASKA MN 55318